You're Careful, Yet Always Sick. Here's the Biological Reason.

TLR4 is one of your immune system’s sentinel proteins. It sits on the surface of immune cells and detects bacterial lipopolysaccharides (LPS), compounds found in gram-negative bacteria. When TLR4 recognizes LPS, it triggers an immediate immune alarm: release cytokines, activate white blood cells, prepare for infection. It’s your body’s smoke detector for bacterial threats.

The TLR4 D299G variant, carried by roughly 10% of people with European ancestry, blunts this detection ability. Your TLR4 receptor becomes less sensitive to bacterial signals. Bacteria can establish themselves in your system before your immune alarm even sounds. By the time you feel sick, the infection is already entrenched. Your immune response starts late and has more ground to make up.

This plays out as respiratory infections that linger, stomach bugs that hit harder and last longer, and repeated sinus infections. You don’t get sick more often because you’re exposed to more pathogens; you get sick more often because your body doesn’t recognize threats quickly enough to stop them early.

FUT2 is not a classical immune gene, but it controls something equally critical: which bacteria live in your gut. The FUT2 gene encodes an enzyme that deposits specific sugars (ABH antigens) onto the mucus layer lining your intestines. These sugars act like nutrient markers for beneficial bacteria, particularly Faecalibacterium prausnitzii and Roseburia species, which are anti-inflammatory and strengthen your immune barrier. If you secrete these markers (secretor status), beneficial bacteria thrive. If you don’t (non-secretor status), they struggle to establish themselves.

Roughly 20-25% of people carry FUT2 variants that make them non-secretors. Non-secretors have dramatically different gut microbiomes, with fewer protective bacteria and greater susceptibility to pathogenic colonization. Your gut barrier becomes compromised. Pathogens that normally get outcompeted by beneficial bacteria instead find a foothold.

The result is a vicious cycle: recurrent GI infections, post-infectious IBS, and systemic infections that seed from gut dysbiosis. You’re not just getting sick more often; your own microbiome is working against you.

Vitamin D does far more than strengthen bones. In your immune cells, vitamin D binds to the vitamin D receptor (VDR), unlocking the expression of antimicrobial peptides called cathelicidins and defensins. These peptides directly kill bacteria, viruses, and fungi. Without functional VDR, your immune cells cannot activate these defenses even if you have adequate vitamin D in your blood. The vitamin D is there; your cells simply can’t use it.

The VDR gene has multiple common variants (FokI, BsmI, ApaI), with FokI being particularly important. Roughly 50% of the population carries at least one lower-function variant. People with these variants require higher circulating vitamin D to achieve the same immune function as those with the normal variant. A vitamin D level of 30 ng/mL, which most doctors consider adequate, may be functionally insufficient for your immune cells.

You may be someone who takes vitamin D regularly, maintains a level that your doctor says is normal, yet remains vulnerable to infections. Your immune cells are simply not activating their antimicrobial defenses because your VDR is not efficiently translating vitamin D into immune action.

Your immune cells don’t directly encounter pathogens. Instead, other cells break down bacteria and viruses into small peptide fragments and present them on molecules called MHC/HLA proteins, like displaying a wanted poster. Your immune cells scan these posters and decide what to attack. HLA-DQ2 is one of these presentation molecules, and it has profound effects on what your immune system can and cannot recognize.

HLA-DQ2 is carried by roughly 25-30% of people with European ancestry. But here’s the critical point: the specific variant you carry determines which pathogens your immune cells can see. Some HLA-DQ2 variants present a wide range of pathogenic antigens efficiently; others are more restricted. Certain pathogens may be essentially invisible to your immune system because your HLA-DQ2 variant cannot present them effectively. You’re not immune deficient; you’re selectively blind to certain threats.

This shows up as recurrent infections with specific pathogen types (you catch every flu but rarely get bacterial sinus infections, for example). Your immune system can mount a strong response to viruses it can see, but other pathogens slip through because your HLA molecule doesn’t display them.

TNF (tumor necrosis factor-alpha) is not the bacteria-killer; it’s the alarm bell that recruits killers. When your immune system detects infection, TNF is released to signal white blood cells to migrate to the infected tissue, increase vascular permeability, trigger fever, and amplify inflammation. TNF is essential. But like any alarm, too much TNF becomes toxic, turning your immune response into collateral damage.

The TNF -308G>A variant, carried by roughly 30% of people with European ancestry, increases baseline TNF production. Your immune cells are a bit more hair-trigger; they release TNF more readily and in higher amounts. You mount a more aggressive inflammatory response to every infection, which sounds protective but often backfires. The inflammation causes more tissue damage, prolongs recovery, and exhausts your immune system faster.

This appears as infections that hit hard and leave you devastated, lingering fatigue and malaise after you’ve supposedly cleared the pathogen, and a tendency toward autoimmune flares after infections. Your immune system is working too hard, burning itself out.

Interleukin-1 beta (IL-1B) is one of the first cytokines your immune system releases in response to infection or injury. It triggers fever, local inflammation, immune cell recruitment, and tissue remodeling. IL-1B is critical for pathogen clearance, but excessive IL-1B causes disproportionate tissue damage and chronic inflammation.

The IL1B rs16944 variant, carried by roughly 35-40% of the population, increases IL-1B production in response to immune triggers. Your inflammatory response to infection is more robust and rapid, which accelerates pathogen killing but also amplifies collateral damage and post-infection inflammation. You clear infections quickly, but at the cost of severe symptoms and prolonged recovery.

You notice this as intense acute infection symptoms (high fever, severe body aches, significant fatigue), rapid progression from feeling fine to very sick, and weeks of post-infection malaise even after the pathogen is cleared. Your immune response is effective but brutal.